Oct 2017

Counterfeit Drug Industry: The Role of Complex Supply Chains

The buzz: “Although counterfeit drug production was originally concerned with lifestyle medications treating non-life threatening conditions, the industry has expanded to produce nearly every type of medicine” (cnbc.com/id/44759526). The World Health Organization (WHO) estimates ... Show More

56m 26s

Oct 2017

Blockchain Technology: A Hit or A Miss for Supply Chain Networks?

The buzz: “We thought big data was big, but the potential quantization and tracking and administration of all classes of activity and reality via blockchain technology…hints at the next orders-of-magnitude...” (Melanie Swan). Based its hyped ability to drive end-to-end value, eli ... Show More

57m 49s

Aug 2017

Stopping Value Leakage: Digital Transformation for Supply Chain

The buzz: “When you calculate the scale of costs that leak from the supply chain, it reveals astonishing waste.” (Pete Loughlin, Supply Chain Finance July 11, 2012) You bought a house years ago. Your family grew and you need to upgrade or buy a new house to fit your current lifes ... Show More

54m 30s

Jan 2020

The pharmacists fighting high drug prices

If you had a rare disease and the only drug that could help you suddenly shot up in price how would you feel? What if your health service or insurer decided it was too expensive and they wouldn’t fund it any more? This is the problem facing some patients in the Netherlands.In ord ... Show More

23m 40s

Aug 2022

You shouldn't have to choose between filling your prescriptions and paying bills | Kiah Williams

As prescription drug costs skyrocket in the US, thousands of people are forced to forgo lifesaving medications -- all while manufacturers and health care facilities systematically destroy perfectly good, surplus pills. Kiah Williams shares how SIRUM -- a nonprofit that delivers u ... Show More

14m 38s

Nov 2018

Orphan Drugs

We chronicle the epic struggle to get drugs that treat very rare diseases on the market, and the unintended consequence of that fight, which affected the cost of all kinds of drugs. This is a strange story that involves a hit 70s TV show, a fake march on Washington, a courageous ... Show More

27m 39s

Sep 2023

Why One Drug Company Held Back a Better Drug

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.Rebecca Robbins, who co ... Show More

35m 38s

Jun 2024

Trillion Dollar Shot, Episode 4: The Disruptors

The rising popularity of GLP-1 drugs could cause all kinds of ripple effects. According to one estimate, 9% of the U.S. population could be on Ozempic or similar medications by 2030. Meanwhile, drugmakers are already developing the next generation of weight-loss drugs and researc ... Show More

42m 15s

Jan 2024

Novo Nordisk (Ozempic)

Last year Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, overtook LVMH to become Europe’s most valuable company. And the pull for Acquired to finally tackle healthcare (18% of US GDP!) became too strong for us to resist. While we didn’t know much about ... Show More

3h 42m

Feb 2023

What's wrong with e-pharmacies?

A few days ago the Central Drugs Standard Control Organization (CDSCO) sent out notices to 20 online pharmacies. The ones you’re probably used to buying medicines from ― Tata 1mg, Netmeds, Apollo, etc. The Chemists Association threatened to go on a strike against e-pharmacies too ... Show More

6m 45s

Encore: Counterfeit Drug Industry: The R...